Softigel by Procaps will be attending CPhi North America´s second edition once again.
Its team of experts will be delighted to sit with you, discuss mutual opportunities and live the Softigel experience.
Softigel by Procaps offers customers full-service, turnkey solutions in over-the-counter (OTC) and prescription products thanks to its softgel development and manufacturing expertise.
The company is focused on developing complex products encapsulated in softgel dosage forms and other delivery systems, high potency active pharmaceutical ingredients (API), differentiated OTC products and nutritional supplements in novel technologies.
Softigel offers a wide range of OTC monograph products in different softgel technologies, with flexible options including customised packaging solutions that range from pack development to full commercial-scale packaging with modern, state-of-the-art equipment to bring value and flexibility to our customers’ supply chains.
The company is one of the worlds´ largest softgel encapsulators, offering its customers deep gelatin and formulation expertise and regulatory support through all cycle stages. Its softgel facilities are approved by the US Food and Drug Administration (FDA), the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Therapeutic Goods Administration (TGA).
At CPhI North America, Softigel seeks new OTC consumer healthcare, generic Rx and pharma customers with collaboration opportunities inside the US, other highly regulated markets or elsewhere worldwide, interested in the development of single to complex formulations in our advanced softgel dosage forms, clinical manufacturing, commercial manufacturing, tech-transfer, delivering the expertise you need and the innovation you demand.
Softigel will be present from 24April to 26 April at the Pennsylvania Convention Center, Stand # 1301.